Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA grants Cyclacel orphan designation for sapacitabine in AML and MDS

July 5, 2010

Banyu discovers Wee1 kinase inhibitors for cancer therapy

July 5, 2010

Preliminary phase I data on HDAC inhibitor CHR-3996 in advanced solid tumors disclosed

July 5, 2010

Eisai plans to submit sNDA to the FDA for Dacogen in AML

July 2, 2010

Progen and Medigen sign collaboration agreement for muparfostat in cancer

July 2, 2010

Threshold initiates phase II TH-302 trial in advanced pancreatic cancer

July 2, 2010

Affitech begins preclinical development of human antibodies for cancer treatment

July 2, 2010

Novartis identifies new VEGFR-2 inhibitors

July 2, 2010

Merck KGaA describes new HSP 90 inhibitors

July 2, 2010

Ridaforolimus shows promise in pediatric patients with refractory solid tumors

July 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...